Partnership expands access to high-quality NAMs, streamlines ordering and data management, and enhances comparative ...
VivoSim Demonstrates Leadership in Field through AI-enabled NAMkind™ Liver and Intestine with High Accuracy Results, ...
Workers who handle graphene as a dry powder can be exposed to airborne concentrations far above any proposed safety benchmark ...
New machine learning framework predicts promising nucleoside hydrogels before they are synthesized and tested in the ...
VivoSim Labs, Inc. (NASDAQ: VIVS) started outlower Monday. The San Diego-based company, a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced that ...
An artificial intelligence (AI) model capable of simultaneously predicting the likelihood of cancer occurring in multiple ...
This review finds that copper nanoparticles can enhance the performance of vegetable oils as bio-lubricants by reducing ...
Building on the success of our first volume, this Research Topic continues to address one of the most pressing challenges in ...
Clinical Trials Arena on MSN
Non-animal models at inflection point, but hedging expectations crucial
While NAMs could revolutionise preclinical development, experts warn that they won’t phase out animal testing for “a long ...
Periodontitis is one of the most common chronic inflammatory diseases worldwide and a leading cause of tooth loss in adults.
Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery BOSTON, June 29, 2026 /PRNewswire/ -- Xellar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results